公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
公司地址 The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
電話號碼 +353 17094000
傳真號碼 --
公司網頁 https://www.perrigo.com
員工數量 8100
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Matthew John Winterman Executive Vice President, Product Supply, Operations Strategy and Transformation Officer -- 26/02/2026
Mr. Eduardo Guarita Bezerra Principal Accounting Officer, Executive Vice President and Chief Financial Officer 美元 755.30K 26/02/2026
Mr. Robert Willis Executive Vice President and Chief Human Resources Officer -- 26/02/2026
Dr. David Ball Executive Vice President and Chief Brand and Digital Officer -- 26/02/2026
Mr. Charles Atkinson Executive Vice President, General Counsel and Secretary -- 26/02/2026
Ms. Abbie Lennox Executive Vice President and Chief Science Officer -- 26/02/2026
Mr. Patrick Lockwood Taylor Director, President and Chief Executive Officer 美元 1.20M 26/02/2026
Mr. Roberto Khoury Executive Vice President and Chief Commercial Officer 美元 325.07K 26/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Jeffrey B. Kindler, J.D. Independent Director 26/02/2026
Ms. Julia M. Brown Independent Director 26/02/2026
Mr. Albert A. Manzone Independent Director 26/02/2026
Ms. Adriana Karaboutis Independent Director 26/02/2026
Mr. Donal O'Connor Independent Director 26/02/2026
Mr. Bradley A. Alford Independent Director 26/02/2026
Mr. Geoffrey M. Parker Independent Director 26/02/2026
Mr. Orlando D. Ashford Chairman of the Board 26/02/2026
Mr. Patrick Lockwood Taylor Director, President and Chief Executive Officer 26/02/2026
Mr. Kevin Egan Independent Director 26/02/2026
Mr. Jonas Samuelson Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:23)
代號 名稱 佔比% 持有日期
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
OMFLInvesco Russell 1000® Dynamic Mltfct ETF0.02%27/02/2026
VONEVanguard Russell 1000 ETF0.02%31/01/2026
PILLDirexion Daily Phrmctcl&MdclBl3XShrsETF0.01%26/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.01%27/02/2026
JPMEJPMorgan Divers Ret US Mid Cp Eq ETF0.01%27/02/2026
FABFirst Trust Multi Cap Val AlphaDEX® ETF0.01%26/02/2026
SMLVState Street® SPDR® USSmCapLowVolIndETF0.01%27/02/2026
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
DFUVDimensional US Marketwide Value ETF0.01%27/02/2026
WSMLiShares MSCI World Small-Cap ETF0.01%28/02/2026
GRXGabelli Health & Wellness0.01%31/12/2025
JDIVJPMorgan US Dividend ETF0.01%31/08/2022
ONEVStt Strt® SPDR® Russell 1000 LwVolFocETF0.005%27/02/2026
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.005%26/02/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.005%27/02/2026
MFDXPIMCO RAFI Dyn Multi-Factor Intl Eq ETF0.004%25/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
ISCBiShares Morningstar Small-Cap ETF0.004%28/02/2026
  1    2    3   4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.